Tumor suppressor maspin as a modulator of host immune response to cancer

di Dzinic, Sijana H., Bernardo, M. Margarida, Oliveira, Daniel S. M., Wahba, Marian, Sakr, Wael, Sheng, Shijie
Pubblicato in Bosn J Basic Med Sci (2015)

The Opportunity of Precision Medicine for Breast Cancer with Context-Sensitive Tumor Suppressor Maspin

di Bernardo, Margarida M, Dzinic, Sijana H, Matta, Maria J, Dean, Ivory, Saker, Lina, Sheng, Shijie
Pubblicato in J Cell Biochem (2017)

Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review

di Sheng, Shijie, Bernardo, M. Margarida, Dzinic, Sijana H., Chen, Kang, Heath, Elisabeth I., Sakr, Wael A.
Pubblicato in Cancer Metastasis Rev (2018)

The secretion and biological function of tumor suppressor maspin as an exosome cargo protein

di Dean, Ivory, Dzinic, Sijana H, Bernardo, M. Margarida, Zou, Yi, Kimler, Vickie, Li, Xiaohua, Kaplun, Alexander, Granneman, James, Mao, Guangzhao, Sheng, Shijie
Pubblicato in Oncotarget (2016)

Identification of an Intrinsic Determinant Critical for Maspin Subcellular Localization and Function

di Dzinic, Sijana H., Kaplun, Alexander, Li, Xiaohua, Bernardo, Margarida, Meng, Yonghong, Dean, Ivory, Krass, David, Stemmer, Paul, Shin, Namhee, Lonardo, Fulvio, Sheng, Shijie
Pubblicazione 2013

A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate canc...

di Thakur, Manish K., Heilbrun, Lance K., Sheng, Shijie, Stein, Mark, Liu, Glenn, Antonarakis, Emmanuel S., Vaishampayan, Ulka, Dzinic, Sijana H., Li, Xiaohua, Freeman, Stacy, Smith, Daryn, Heath, Elisabeth I.
Pubblicato in Invest New Drugs (2015)

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

di Luedtke, Daniel A., Su, Yongwei, Ma, Jun, Li, Xinyu, Buck, Steven A., Edwards, Holly, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Lin, Hai, Taub, Jeffrey W., Ge, Yubin
Pubblicato in Signal Transduct Target Ther (2020)

Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-mutated Acute Myeloid Leukemia

di Ma, Jun, Zhao, Shoujing, Qiao, Xinan, Knight, Tristan, Edwards, Holly, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Wang, Guan, Zhao, Lijing, Lin, Hai, Wang, Yue, Taub, Jeffrey W., Ge, Yubin
Pubblicato in Clin Cancer Res (2019)

Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia

di Li, Xinyu, Su, Yongwei, Madlambayan, Gerard, Edwards, Holly, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Ma, Jun, Knight, Tristan, Wang, Guan, Wang, Yue, Yang, Jay, Taub, Jeffrey W., Lin, Hai, Ge, Yubin
Pubblicato in Haematologica (2019)

Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity

di Bernardo, M. Margarida, Kaplun, Alexander, Dzinic, Sijana H., Li, Xiaohua, Irish, Jonathan, Mujagic, Adelina, Jakupovic, Benjamin, Back, Jessica B., Van Buren, Eric, Han, Xiang, Dean, Ivory, Chen, Yong Q., Heath, Elisabeth, Sakr, Wael, Sheng, Shijie
Pubblicato in Cancer Res (2015)

Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation

di Liu, Fangbing, Kalpage, Hasini A., Wang, Deying, Edwards, Holly, Hüttemann, Maik, Ma, Jun, Su, Yongwei, Carter, Jenna, Li, Xinyu, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Wang, Guan, Taub, Jeffrey W., Ge, Yubin
Pubblicato in Cancers (Basel) (2020)

Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma

di Dzinic, Sijana H., Mahdi, Zaid, Bernardo, M. Margarida, Vranic, Semir, Beydoun, Haya, Nahra, Nadine, Alijagic, Amra, Harajli, Deanna, Pang, Aaron, Saliganan, Dan M., Rahman, Abid M., Skenderi, Faruk, Hasanbegovic, Berisa, Dyson, Gregory, Beydoun, Rafic, Sheng, Shijie
Pubblicato in PLoS One (2019)

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

di Qiao, Xinan, Ma, Jun, Knight, Tristan, Su, Yongwei, Edwards, Holly, Polin, Lisa, Li, Jing, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Wang, Jian, Lin, Hai, Wang, Yue, Wang, Liping, Wang, Guan, Taub, Jeffrey W., Ge, Yubin
Pubblicato in Blood Cancer J (2021)

The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia

di Li, Xinyu, Su, Yongwei, Hege, Katie, Madlambayan, Gerard, Edwards, Holly, Knight, Tristan, Polin, Lisa, Kushner, Juiwanna, Dzinic, Sijana H., White, Kathryn, Yang, Jay, Miller, Regan, Wang, Guan, Zhao, Lijing, Wang, Yue, Lin, Hai, Taub, Jeffrey W., Ge, Yubin
Pubblicato in Haematologica (2020)

Maspin expression in prostate tumor elicits host anti-tumor immunity

di Dzinic, Sijana H., Chen, Kang, Thakur, Archana, Kaplun, Alexander, Daniel Bonfil, R., Li, Xiaohua, Liu, Jason, Margarida Bernardo, M., Saliganan, Allen, Back, Jessica B., Yano, Hiroshi, Schalk, Dana L., Tomaszewski, Elyse N., Beydoun, Ahmed S., Dyson, Gregory, Mujagic, Adelina, Krass, David, Dean, Ivory, Mi, Qing-Sheng, Heath, Elisabeth, Sakr, Wael, Lum, Lawrence G., Sheng, Shijie
Pubblicato in Oncotarget (2014)

An essential role of maspin in embryogenesis and tumor suppression

di Dzinic, Sijana H., Bernardo, M. Margarida, Li, Xiaohua, Fernandez-Valdivia, Rodrigo, Ho, Ye-Shih, Mi, Qing-Sheng, Bandyopadhyay, Sudeshna, Lonardo, Fulvio, Vranic, Semir, Oliveira, Daniel S. M., Bonfil, R. Daniel, Dyson, Gregory, Chen, Kang, Omerovic, Almasa, Sheng, Xiujie, Han, Xiang, Wu, Dinghong, Bi, Xinling, Cabaravdic, Dzenana, Jakupovic, Una, Wahba, Marian, Pang, Aaron, Harajli, Deanna, Sakr, Wael A, Sheng, Shijie
Pubblicato in Cancer Res (2016)

Novel pyrrolo[3,2-d]pyrimidine compounds target mitochondrial and cytosolic one-carbon metabolism with broad-spectrum antitumor efficacy

di Dekhne, Aamod S., Shah, Khushbu, Ducker, Gregory S., Katinas, Jade M., Wong-Roushar, Jennifer, Nayeen, Junayed, Doshi, Arpit, Ning, Changwen, Bao, Xun, Frühauf, Josephine, Liu, Jenney, Wallace-Povirk, Adrianne, O’Connor, Carrie, Dzinic, Sijana H., White, Kathryn, Kushner, Juiwanna, Kim, Seongho, Hüttemann, Maik, Polin, Lisa, Rabinowitz, Joshua D., Li, Jing, Hou, Zhanjun, Dann, Charles E., Gangjee, Aleem, Matherly, Larry H.
Pubblicato in Mol Cancer Ther (2019)